Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

37.08

-0.38 (-1.01%)

At close: Mar 6, 2026, 4:00 PM EST

37.80

+0.72 (1.94%)

After-hours: Mar 6, 2026, 7:36 PM EST

Cogent Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-328.94	-255.86	-192.41	-140.24	-72.27
Depreciation & Amortization	4.58	4.35	3.59	5.88	1.99
Stock-Based Compensation	46.08	39.74	30.62	18.37	11.69
Other Adjustments	5.82	-7.62	-6.87	-3.39	-0.34
Changes in Accounts Payable	-2.51	1.36	4.81	2.36	2.75
Changes in Accrued Expenses	10.69	15.96	8.17	9.59	3.43
Changes in Other Operating Activities	-0.17	-5.72	-1.54	-11.19	-6.01
Operating Cash Flow	-264.44	-207.79	-153.62	-118.64	-58.76
Capital Expenditures	-1.55	-0.57	-2.8	-6.86	-1.72
Purchases of Investments	-687.17	-255.6	-348.8	-177.86	-
Proceeds from Sale of Investments	289.2	294.45	253.78	60	-
Investing Cash Flow	-399.53	38.28	-97.82	-124.72	-1.72
Long-Term Debt Issued	272.39	-	-	-	-
Long-Term Debt Repaid	-54.64	-	-	-	-
Net Long-Term Debt Issued (Repaid)	217.76	-	-	-	-
Issuance of Common Stock	712	214.45	1.72	163.56	38.06
Net Common Stock Issued (Repurchased)	712	214.45	1.72	163.56	38.06
Other Financing Activities	-51.52	-	-	-	-0.09
Financing Cash Flow	878.23	214.45	163.54	163.56	37.98
Net Cash Flow	214.26	44.94	-87.91	-79.8	-22.51
Free Cash Flow	-266	-208.36	-156.42	-125.5	-60.48
Free Cash Flow Per Share	-2.06	-2.01	-1.96	-2.14	-1.56
Levered Free Cash Flow	-100.14	-240.49	-180.18	-140.48	-71.83
Unlevered Free Cash Flow	-322.32	-260.57	-195.9	-148.07	-75.1

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q